Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MUSTANG BIO, INC. Director's Dealing 2017

Jul 21, 2017

35167_dirs_2017-07-20_caf952b3-7702-4e9b-8e6a-2ea524db5ba9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MUSTANG BIO, INC. (NONE)
CIK: 0001680048
Period of Report: 2016-09-26

Reporting Person: ROSENWALD LINDSAY A MD (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (Restricted) 10000 Direct

Footnotes

F1: The 10,000 shares are restricted common stock, which will vest on 6/30/2020, subject to Dr. Rosenwald's continued service on the board on such date.